Clinical Trials
34 trialsEstablishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
The Efficacy of Allo-HSCT in ND HR-CBF-AML
Ruijin Hospital
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
M.D. Anderson Cancer Center
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Mayo Clinic
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Medical College of Wisconsin
ECS Weight
University of Kansas Medical Center
BCB-Sarcomes
Institut Bergonié
Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Ruijin Hospital
On-CALL
Region Skane
AGAMENON
Fundación Sociedad Española de Oncologia Médica
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Samsung Medical Center
NORPACT-3
Oslo University Hospital
CaSPiN
Turku University Hospital
REBORN
University of Roma La Sapienza
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
RenJi Hospital
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
University of Colorado, Denver
Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
Chinese PLA General Hospital
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
IRCCS San Raffaele
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Qilu Hospital of Shandong University
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
Tumor Regression Grade As Predictor of Adjuvant Therapy
Fujian Medical University Union Hospital
RESHMART
Mahatma Gandhi Institute of Medical Sciences
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Changzhi People's Hospital Affiliated to Changzhi Medical College
A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC
Universitaire Ziekenhuizen KU Leuven
CREATE
Hunan Province Tumor Hospital
Tumor Vaccines for Solid Tumors
Huashan Hospital
PORTRAIT
Vall d'Hebron Institute of Oncology
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
MITO9B
National Cancer Institute, Naples